The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: A meta-analysis

被引：37

作者：

Zhao, Shu-Liang ^{[1
]}

Fang, Jing-Yuan ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Inst Digest Dis, Shanghai 200001, Peoples R China

来源：

CANCER INVESTIGATION | 2008年 / 26卷 / 03期

关键词：

stomach cancer; chemotherapy; clinical trials;

D O I：

10.1080/07357900701834686

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To evaluate the effect of adjuvant chemotherapy on survival rates after curative resection of gastric cancer, MEDLINE (1969-2006), EMBASE (1974-2006), bibliographies, and review articles were searched for relevant articles. The meta-analysis was finally based on 15 trials that included 3212 patients. RR for death in the treated group was 0.90 (95% CI, 0.84-0.96) (P = 0.0010). Little or no significant benefits were suggested in subgroup analyses between different population and regimens either. Postoperative adjuvant chemotherapy for gastric cancer confers slightly significant benefits compared to the surgery only group. The prognoses after surgery may differ among various population groups or because of different regimens.

引用

页码：317 / 325

页数：9

共 63 条

[1] A CONTROLLED, PROSPECTIVE, RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY OR RADIOTHERAPY IN RESECTABLE GASTRIC-CANCER - INTERIM-REPORT [J].

ALLUM, WH ;

HALLISSEY, MT ;

WARD, LC ;

HOCKEY, MS .

BRITISH JOURNAL OF CANCER, 1989, 60 (05) :739-744

[2]

ALLUM WH, 1989, LANCET, V1, P571

[3]

[Anonymous], 1988, Br J Surg, V75, P1100

[4] Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group [J].

Bajetta, E ;

Buzzoni, R ;

Mariani, L ;

Beretta, E ;

Bozzetti, F ;

Bordogna, G ;

Aitini, E ;

Fava, S ;

Schieppati, G ;

Pinotti, G ;

Visini, M ;

Ianniello, G ;

Di Bartolomeo, M .

ANNALS OF ONCOLOGY, 2002, 13 (02) :299-307

[5]

BOKU T, 1989, SURGERY, V105, P585

[6] Extended lymph-node dissection for gastric cancer [J].

Bonenkamp, JJ ;

Hermans, J ;

Sasako, M ;

van de Velde, CJH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914

[7] Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer:: 7-year results of the FFCD randomized phase III trial (8801) [J].

Bouché, O ;

Ychou, M ;

Burtin, P ;

Bedenne, L ;

Ducreux, M ;

Lebreton, G ;

Baulieux, J ;

Nordlinger, B ;

Martin, C ;

Seitz, JF ;

Tigaud, JM ;

Echinard, E ;

Stremsdoerfer, N ;

Milan, C ;

Rougier, P .

ANNALS OF ONCOLOGY, 2005, 16 (09) :1488-1497

[8] Hyperfractionated or accelerated radiotherapy in head and neck cancer:: a meta-analysis [J].

Bourhis, Jean ;

Overgaard, Jens ;

Audry, Helene ;

Ang, Kian K. ;

Saunders, Michele ;

Bernier, Jacques ;

Horiot, Jean-Claude ;

Le Maitre, Aurlie ;

Pajak, Thomas F. ;

Paulsen, Michael G. ;

O'Sullivan, Brian ;

Dobrowsky, Werner ;

Hliniak, Andrzej ;

Skladowski, Krzysztof ;

Hay, John H. ;

Pinto, Luiz H. J. ;

Fallai, Carlo ;

Fu, Karen K. ;

Sylvester, Richard ;

Pignon, Jean-Pierre .

LANCET, 2006, 368 (9538) :843-854

[9] Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer [J].

Chipponi, J ;

Huguier, M ;

Pezet, D ;

Basso, N ;

Hay, JM ;

Quandalle, P ;

Jaeck, D ;

Fagniez, PL ;

Gainant, A .

AMERICAN JOURNAL OF SURGERY, 2004, 187 (03) :440-445

[10] Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer [J].

Cirera, L ;

Balil, A ;

Batiste-Alentorn, E ;

Tusquets, I ;

Cardona, T ;

Arcusa, A ;

Jolis, L ;

Saigí, E ;

Guasch, I ;

Badia, A ;

Boleda, M .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3810-3815

← 1 2 3 4 5 6 7 →